• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    Tekmira Pharmaceuticals Corporation (TKMR)

    -NasdaqCM
    10.83 Up 0.58(5.66%) Jul 31, 4:00PM EDT
    Add to Portfolio
    Prev Close:10.25
    Open:10.25
    Bid:9.40 x 3000
    Ask:11.18 x 300
    1y Target Est:25.92
    Beta:-1.12
    Next Earnings Date: 5-Aug-15TKMR Earnings announcement
    Day's Range:10.07 - 11.03
    52wk Range:10.02 - 29.93
    Volume:670,045
    Avg Vol (3m):687,155
    Market Cap:587.25M
    P/E (ttm):N/A
    EPS (ttm):-1.36
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    TKMRUp 5.66%587.25M
    MRNADown 6.07%10.00M
    RXIIDown 0.24%23.46M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):36.55
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Tekmira Pharmaceuticals Corporation, a biopharmaceutical company, focuses on the research and development of RNA interference therapeutics; and provides lipid nanoparticle delivery technology to pharmaceutical partners in Canada. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback